Showing results (1-10 of 1,526) with videos related to

Sort By:
Pageof 153
Discover Oncology|August 25, 2025
Targeting the CD47-SIRPalpha checkpoint in multiple myelomaTao Ming Sim, Wee Joo Chng, Haiyan Liu, et al.
Cancers|November 26, 2022
Tumor-Associated Macrophages and Related Myelomonocytic Cells in the Tumor Microenvironment of Multiple MyelomaSamuel S Y Wang, Wee Joo Chng, Haiyan Liu, et al.
Cancers|May 28, 2019
STAT3: A Promising Therapeutic Target in Multiple MyelomaPhyllis S Y Chong, Wee-Joo Chng, Sanjay de Mel
Current Hematologic Malignancy Reports|February 18, 2016
Risk Stratification in Multiple MyelomaMelissa Gaik-Ming Ooi, Sanjay de Mel, Wee Joo Chng
Cells|March 7, 2020
Immunotherapy in Multiple MyelomaCinnie Yentia Soekojo, Melissa Ooi, Sanjay de Mel, et al.
Biomed Research International|August 8, 2014
Implications of heterogeneity in multiple myelomaSanjay de Mel, Su Hong Lim, Moon Ley Tung, et al.
International Journal of Molecular Sciences|June 13, 2018
Potential Clinical Application of Genomics in Multiple MyelomaCinnie Yentia Soekojo, Sanjay de Mel, Melissa Ooi, et al.
Frontiers in Oncology|June 27, 2022
Immunoglobulin M Monoclonal Gammopathies of Clinical SignificanceLouis-Pierre Girard, Cinnie Yentia Soekojo, Melissa Ooi, et al.
Cancer Biology & Therapy|April 23, 2016
Bortezomib-related neuropathy may mask CNS relapse in multiple myeloma: A call for diligenceMuhammad Bilal Abid, Sanjay De Mel, Muhammad Abbas Abid, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 6, 2020
Bacterial Infection Among Patients With Multiple Myeloma Treated With Bortezomib-based Induction Therapy: Real-World Experience in an Asian Cancer CenterCinnie Yentia Soekojo, Jia Zhen Low, Jaslyn Oh, et al.
Pageof 153